Cutaneous Radiation Injury Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 61 pages | ID: C7520977B968EN
Market Monitor Global

Abstracts

Cutaneous radiation injury occurs on a functional, cellular, and gross level. Radiation therapy is the major modality in the management of cancer treatment along with the surgery and chemotherapy. Most common side effect of the radiation is the acute skin reaction which usually range from mild to confluent moist desquamation.

This report contains market size and forecasts of Cutaneous Radiation Injury Drug in Global, including the following market information:

Global Cutaneous Radiation Injury Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cutaneous Radiation Injury Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cutaneous Radiation Injury Drug include Merck, Novartis, Johnson & Johnson, Pfizer, Amgen, Roche, Eli Lily, AstraZeneca and Teva. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cutaneous Radiation Injury Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cutaneous Radiation Injury Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cutaneous Radiation Injury Drug Market Segment Percentages, by Type, 2021 (%)

• Oral Drug
• Topical Drug

Global Cutaneous Radiation Injury Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cutaneous Radiation Injury Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharnacies
• Retail Pharmacies

Global Cutaneous Radiation Injury Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cutaneous Radiation Injury Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cutaneous Radiation Injury Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cutaneous Radiation Injury Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck
• Novartis
• Johnson & Johnson
• Pfizer
• Amgen
• Roche
• Eli Lily
• AstraZeneca
• Teva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cutaneous Radiation Injury Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cutaneous Radiation Injury Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CUTANEOUS RADIATION INJURY DRUG OVERALL MARKET SIZE

2.1 Global Cutaneous Radiation Injury Drug Market Size: 2021 VS 2028
2.2 Global Cutaneous Radiation Injury Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cutaneous Radiation Injury Drug Players in Global Market
3.2 Top Global Cutaneous Radiation Injury Drug Companies Ranked by Revenue
3.3 Global Cutaneous Radiation Injury Drug Revenue by Companies
3.4 Top 3 and Top 5 Cutaneous Radiation Injury Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cutaneous Radiation Injury Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cutaneous Radiation Injury Drug Players in Global Market
  3.6.1 List of Global Tier 1 Cutaneous Radiation Injury Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cutaneous Radiation Injury Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cutaneous Radiation Injury Drug Market Size Markets, 2021 & 2028
  4.1.2 Oral Drug
  4.1.3 Topical Drug
4.2 By Type - Global Cutaneous Radiation Injury Drug Revenue & Forecasts
  4.2.1 By Type - Global Cutaneous Radiation Injury Drug Revenue, 2017-2022
  4.2.2 By Type - Global Cutaneous Radiation Injury Drug Revenue, 2023-2028
  4.2.3 By Type - Global Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cutaneous Radiation Injury Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharnacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Cutaneous Radiation Injury Drug Revenue & Forecasts
  5.2.1 By Application - Global Cutaneous Radiation Injury Drug Revenue, 2017-2022
  5.2.2 By Application - Global Cutaneous Radiation Injury Drug Revenue, 2023-2028
  5.2.3 By Application - Global Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cutaneous Radiation Injury Drug Market Size, 2021 & 2028
6.2 By Region - Global Cutaneous Radiation Injury Drug Revenue & Forecasts
  6.2.1 By Region - Global Cutaneous Radiation Injury Drug Revenue, 2017-2022
  6.2.2 By Region - Global Cutaneous Radiation Injury Drug Revenue, 2023-2028
  6.2.3 By Region - Global Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cutaneous Radiation Injury Drug Revenue, 2017-2028
  6.3.2 US Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.3.3 Canada Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.3.4 Mexico Cutaneous Radiation Injury Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cutaneous Radiation Injury Drug Revenue, 2017-2028
  6.4.2 Germany Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.4.3 France Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.4.4 U.K. Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.4.5 Italy Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.4.6 Russia Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.4.8 Benelux Cutaneous Radiation Injury Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cutaneous Radiation Injury Drug Revenue, 2017-2028
  6.5.2 China Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.5.3 Japan Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.5.4 South Korea Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.5.6 India Cutaneous Radiation Injury Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cutaneous Radiation Injury Drug Revenue, 2017-2028
  6.6.2 Brazil Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.6.3 Argentina Cutaneous Radiation Injury Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cutaneous Radiation Injury Drug Revenue, 2017-2028
  6.7.2 Turkey Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.7.3 Israel Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Cutaneous Radiation Injury Drug Market Size, 2017-2028
  6.7.5 UAE Cutaneous Radiation Injury Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Merck
  7.1.1 Merck Corporate Summary
  7.1.2 Merck Business Overview
  7.1.3 Merck Cutaneous Radiation Injury Drug Major Product Offerings
  7.1.4 Merck Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.1.5 Merck Key News
7.2 Novartis
  7.2.1 Novartis Corporate Summary
  7.2.2 Novartis Business Overview
  7.2.3 Novartis Cutaneous Radiation Injury Drug Major Product Offerings
  7.2.4 Novartis Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.2.5 Novartis Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Cutaneous Radiation Injury Drug Major Product Offerings
  7.3.4 Johnson & Johnson Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 Pfizer
  7.4.1 Pfizer Corporate Summary
  7.4.2 Pfizer Business Overview
  7.4.3 Pfizer Cutaneous Radiation Injury Drug Major Product Offerings
  7.4.4 Pfizer Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.4.5 Pfizer Key News
7.5 Amgen
  7.5.1 Amgen Corporate Summary
  7.5.2 Amgen Business Overview
  7.5.3 Amgen Cutaneous Radiation Injury Drug Major Product Offerings
  7.5.4 Amgen Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.5.5 Amgen Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Cutaneous Radiation Injury Drug Major Product Offerings
  7.6.4 Roche Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.6.5 Roche Key News
7.7 Eli Lily
  7.7.1 Eli Lily Corporate Summary
  7.7.2 Eli Lily Business Overview
  7.7.3 Eli Lily Cutaneous Radiation Injury Drug Major Product Offerings
  7.7.4 Eli Lily Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.7.5 Eli Lily Key News
7.8 AstraZeneca
  7.8.1 AstraZeneca Corporate Summary
  7.8.2 AstraZeneca Business Overview
  7.8.3 AstraZeneca Cutaneous Radiation Injury Drug Major Product Offerings
  7.8.4 AstraZeneca Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.8.5 AstraZeneca Key News
7.9 Teva
  7.9.1 Teva Corporate Summary
  7.9.2 Teva Business Overview
  7.9.3 Teva Cutaneous Radiation Injury Drug Major Product Offerings
  7.9.4 Teva Cutaneous Radiation Injury Drug Revenue in Global Market (2017-2022)
  7.9.5 Teva Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cutaneous Radiation Injury Drug Market Opportunities & Trends in Global Market
Table 2. Cutaneous Radiation Injury Drug Market Drivers in Global Market
Table 3. Cutaneous Radiation Injury Drug Market Restraints in Global Market
Table 4. Key Players of Cutaneous Radiation Injury Drug in Global Market
Table 5. Top Cutaneous Radiation Injury Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cutaneous Radiation Injury Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cutaneous Radiation Injury Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cutaneous Radiation Injury Drug Product Type
Table 9. List of Global Tier 1 Cutaneous Radiation Injury Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cutaneous Radiation Injury Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cutaneous Radiation Injury Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cutaneous Radiation Injury Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cutaneous Radiation Injury Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cutaneous Radiation Injury Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cutaneous Radiation Injury Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cutaneous Radiation Injury Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2023-2028
Table 30. Merck Corporate Summary
Table 31. Merck Cutaneous Radiation Injury Drug Product Offerings
Table 32. Merck Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 33. Novartis Corporate Summary
Table 34. Novartis Cutaneous Radiation Injury Drug Product Offerings
Table 35. Novartis Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Cutaneous Radiation Injury Drug Product Offerings
Table 38. Johnson & Johnson Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 39. Pfizer Corporate Summary
Table 40. Pfizer Cutaneous Radiation Injury Drug Product Offerings
Table 41. Pfizer Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 42. Amgen Corporate Summary
Table 43. Amgen Cutaneous Radiation Injury Drug Product Offerings
Table 44. Amgen Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Cutaneous Radiation Injury Drug Product Offerings
Table 47. Roche Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lily Corporate Summary
Table 49. Eli Lily Cutaneous Radiation Injury Drug Product Offerings
Table 50. Eli Lily Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 51. AstraZeneca Corporate Summary
Table 52. AstraZeneca Cutaneous Radiation Injury Drug Product Offerings
Table 53. AstraZeneca Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)
Table 54. Teva Corporate Summary
Table 55. Teva Cutaneous Radiation Injury Drug Product Offerings
Table 56. Teva Cutaneous Radiation Injury Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cutaneous Radiation Injury Drug Segment by Type in 2021
Figure 2. Cutaneous Radiation Injury Drug Segment by Application in 2021
Figure 3. Global Cutaneous Radiation Injury Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cutaneous Radiation Injury Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cutaneous Radiation Injury Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cutaneous Radiation Injury Drug Revenue in 2021
Figure 8. By Type - Global Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 12. US Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 16. Germany Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 24. China Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cutaneous Radiation Injury Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cutaneous Radiation Injury Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Merck Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novartis Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pfizer Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Amgen Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lily Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. AstraZeneca Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Cutaneous Radiation Injury Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)